Profit Track 100

The world’s largest pharmaceutical and biotech companies subscribe to this London company’s market intelligence, forecasts, and news and analysis on the life sciences industry. Chairman Jonathan de Pass, 60, started the business in 1996, and it is now led by chief executive Alex Karle, 47. In 2015, it generated 91% of its sales of £16.7m overseas – with America its largest market – and profits of £3.4m. Last year the company entered China and it is expanding into new overseas markets such as Korea, Taiwan and Australia.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
Year2016
CompanyEvaluate
ActivityLife sciences analyst
LocationCentral London
Profits £0003,406
Sales £00016,743
Staff90
Founded1996
Websitewww.evaluategroup.com

If applicable:

# ebitda * supplied by company † annualised figure